Kanna and Other Substances

Kanna and other substances is a topic that demands careful attention because kanna (Sceletium tortuosum) is a serotonergic botanical whose principal alkaloids — mesembrine, mesembrenone, and mesembrenol — interact meaningfully with the serotonin system. Combining kanna with other psychoactive substances is where things get genuinely risky. Because these alkaloids have documented serotonin transporter (SERT) inhibition activity, mixing kanna with anything else that touches the serotonin system can produce dangerous, unpredictable outcomes. This article covers the key combinations people ask about when considering kanna and other substances, explains why some are outright dangerous, and flags the grey areas where the research simply hasn't caught up yet.

Adult audience (18+). The dosing ranges and effects described in this article apply to adult physiology. This content is not intended for minors.

Disclaimer: This article is for informational purposes only and does not constitute medical advice. Combining kanna with other substances — particularly prescription medications — can be dangerous. Always consult a qualified healthcare professional before combining kanna with any medication or psychoactive substance. If you suspect serotonin syndrome, seek emergency medical attention immediately.

Why Combinations Matter With Kanna

Kanna's alkaloids inhibit the serotonin transporter (SERT) and may also inhibit PDE4, making it pharmacologically active in ways that most botanical supplements are not. Most botanical substances people combine casually — chamomile and valerian, say — act on different receptor systems or share such mild activity that overlap is trivial. Kanna is different. In-vitro data indicates mesembrine inhibits SERT with an IC50 in the nanomolar range, and there is evidence suggesting PDE4 inhibition as well, though the relative contribution of each mechanism in living humans remains unsettled (Harvey et al., 2011). According to a 2014 review by the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), Sceletium tortuosum is among the novel psychoactive botanicals warranting pharmacovigilance attention. What is clear is that kanna produces meaningful serotonergic effects — and serotonin is a system where stacking inputs can tip you from pleasant to medical emergency.

The critical concept here is serotonin syndrome: a cluster of symptoms — agitation, hyperthermia, rapid heart rate above 120 bpm, muscle rigidity, tremor — caused by excessive serotonergic stimulation. It is rare, but it is potentially life-threatening, with mortality rates estimated at 2–12% in severe cases (Boyer & Shannon, 2005). It doesn't require massive doses of any single substance; it requires enough combined serotonergic pressure from multiple sources acting simultaneously.

This is also where the distinction between plant material and concentrated extracts matters enormously. Extracts concentrate the Sceletium alkaloids — primarily mesembrine — relative to raw or fermented plant material, sometimes by a factor of 10–50x depending on the extraction method. The serotonergic interaction risk applies with greater weight to extracts, because the alkaloid load per milligram is substantially higher. If you're thinking about combining kanna with anything, what form of kanna you're using changes the equation.

The Dangerous Combinations

The most dangerous combinations with kanna are those involving any substance that increases serotonin availability — including SSRIs, MAOIs, MDMA, and certain supplements. These are not theoretical risks. They are pharmacologically predictable interactions based on known mechanisms.

SSRIs and SNRIs. Fluoxetine, sertraline, citalopram, venlafaxine, duloxetine — these are the most commonly prescribed antidepressants in Europe, with over 75 million SSRI prescriptions written annually across EU member states. Layering kanna's serotonin reuptake inhibition on top of an SSRI or SNRI is the textbook recipe for serotonin syndrome. Do not combine them. And note: if you've recently stopped an SSRI, the drug and its active metabolites can persist in your body for weeks. Fluoxetine's active metabolite, norfluoxetine, has a half-life of 4–16 days (Hiemke & Härtter, 2000). Stopping your SSRI on a Friday and trying kanna on a Saturday is not a washout period.

MAOIs. Monoamine oxidase inhibitors — whether pharmaceutical (phenelzine, tranylcypromine) or botanical (Syrian rue, Banisteriopsis caapi) — prevent the breakdown of serotonin. Combined with kanna's reuptake inhibition, you get a double hit: more serotonin released and less serotonin cleared. This is arguably the most dangerous pairing on this list. The ayahuasca community has documented cases of serotonin syndrome from combining MAO-inhibiting brews with serotonergic substances (Callaway & Grob, 1998), and kanna falls squarely into that category.

Tricyclic antidepressants. Older drugs like amitriptyline and imipramine also have serotonergic activity alongside their other mechanisms. Same principle applies — do not combine.

MDMA. MDMA floods the synapse with serotonin — studies estimate it can increase extracellular serotonin levels by up to 800% above baseline (Green et al., 2003). Adding kanna's reuptake inhibition to that flood is reckless. Some users report trying this combination; the fact that some people survive reckless things does not make them safe. Serotonin syndrome from MDMA alone is documented; adding a second serotonergic agent raises the probability.

5-HTP and St John's Wort. These are sold as supplements, which makes people assume they're benign in combination. 5-HTP is a direct serotonin precursor — it increases the raw material available. St John's Wort (Hypericum perforatum) inhibits serotonin reuptake through its own mechanism. Either one, combined with kanna, creates the same stacking risk described above.

Classical Psychedelics and Kanna

Classical psychedelics like psilocybin, LSD, and DMT are serotonin 2A receptor agonists whose interaction with kanna remains unstudied in any controlled setting. Their primary mechanism is different from kanna's — they bind to the receptor rather than blocking reuptake — but the serotonin system is interconnected. Increasing synaptic serotonin availability via kanna while simultaneously stimulating serotonin receptors with a classical psychedelic creates an unpredictable pharmacological situation.

Published data on this specific combination is essentially nonexistent. Some users report that kanna taken before or alongside psilocybin alters the character of the experience — but "some users report" is not safety data. The theoretical risk of serotonin syndrome exists, and without controlled studies, there is no way to quantify it. Research from the Beckley Foundation on psilocybin pharmacology has helped map the serotonin 2A agonist pathway in detail, but their work has not examined concurrent SERT inhibition from botanicals like kanna. The cautious position is to avoid this combination, particularly with concentrated kanna extracts where the serotonergic load is higher.

Cannabis and Kanna

Cannabis acts primarily on the endocannabinoid system (CB1 and CB2 receptors), which is mechanistically distinct from serotonin reuptake, so there is no strong pharmacological basis for a dangerous interaction with kanna. Some users describe the combination as producing a calmer, more grounded version of cannabis's effects; others report increased sedation or mild nausea. None of this is backed by controlled research — it sits firmly in the anecdotal category.

The absence of a known dangerous interaction is not the same as a confirmed safe interaction. Cannabis can increase heart rate by 20–50 bpm in the first hour after use; kanna's cardiovascular effects in humans are poorly characterised. If you choose to combine them, the general principle of using less of each than you would alone applies.

Alcohol and Kanna

Alcohol is a CNS depressant acting primarily on GABA receptors and glutamate signalling, making it mechanistically separate from kanna's serotonergic activity. There is no published research on the kanna-alcohol combination specifically. Anecdotally, some users describe kanna as reducing the desire to drink or blunting alcohol's sedative edge, but this is unverified self-report, not evidence for a therapeutic claim.

What is worth noting: alcohol impairs judgement about dosing. If you're drinking and decide to take more kanna — especially an extract — you're making dosing decisions with compromised executive function. That's a practical risk even without a pharmacological interaction.

Caffeine and Kanna

Caffeine is an adenosine receptor antagonist with no serotonergic mechanism and no known interaction pathway with mesembrine. Of all the combinations people ask about when exploring kanna and other substances, this one carries the least theoretical concern. Some users combine kanna with coffee or tea and describe it as producing alert focus without jitteriness — though this is, again, subjective report rather than clinical data.

The Core Principle

The single most important rule when considering kanna and other substances is this: if a substance increases serotonin — whether by blocking reuptake, inhibiting breakdown, increasing synthesis, or directly stimulating serotonin receptors — combining it with kanna raises the risk of serotonin syndrome. The risk scales with dose, with extract potency, and with how many serotonergic inputs are active simultaneously. A person taking an SSRI who adds kanna extract and drinks a St John's Wort tea has three serotonergic agents on board. That is not a grey area; that is a clear danger.

For combinations that don't involve the serotonin system — cannabis, caffeine, most GABAergic herbs — the theoretical risk is lower, but the evidence base is thin to nonexistent. "No known dangerous interaction" is a weaker statement than "demonstrated to be safe." Anyone taking prescription medication of any kind should speak with their prescribing clinician before adding kanna, because drug interactions can be idiosyncratic and individual metabolic variation (particularly CYP450 enzyme polymorphisms) can alter how substances behave in your specific body.

For a deeper look at the serotonin syndrome risk specifically, see the dedicated article Kanna Safety and Side Effects. For dosing considerations across different forms, see Kanna Dosage Guide. For general background on the plant itself, see What Is Kanna in our wiki section. You can also explore our blog post Kanna: Traditional Use to Modern Extract for historical context on how this plant has been used.

Where to Buy Kanna

If you want to buy kanna to explore Sceletium tortuosum on its own terms — without combining it with other substances — you can browse the plant material and extracts in our kanna category. We carry both raw fermented kanna and standardised kanna extracts such as Kanna UC2 extract and Kanna ET2 extract, so you can choose the form that suits your intended use. Whether you want to order kanna powder for sublingual use or get kanna extract capsules for convenience, the product pages include alkaloid content information to help you dose responsibly.

Last updated: April 2026

AZARIUS · References